Whilst research into novel treatments continues, patients should rely on licensed, guideline-recommended therapies under appropriate medical supervision
The anchoring trials are the STEP program (semaglutide for weight management, The New England Journal of Medicine , 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024)
T.HjellvikV.AndersenM.AuvinenA.et al (2017)
Bath applications of 10 M Ex-4 resulted in depolarization of the membrane potential by 5.00.7 mV (from 48.02.2 to 43.01.8 mV, n =6) in six of 21 cells tested (28.5%) (Table 1, Fig
Much of the regulatory fight has focused on which ingredients compounders should be allowed to use